asia pacific regenerative medicine market
DESCRIPTION
Asia-Pacific regenerative market is estimated to reach $9 billion by 2020, from $3 billion in 2013 with a CAGR of 15.04%.Small molecules and biologics show immense potential for the market and estimated to grow at a CAGR of 19%. Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines which are palliative. Technological innovations in stem cell therapy and Tissue engineering, growing prevalence of bone and joint diseases, growing need of orthopaedic surgeries and increase people awareness are the major driving forces for the market.The advancements in nanotechnology and increased in innovation in stem cell therapy account for the further growth of market in this field. The major constrain for the market is regulatory bodies rules and ethical issues related to regenerative medicines and cost of the treatment. Technologically, market is divided into Stem cell therapy, Biomaterial, and tissue engineering. By type of applications, Bone graft substitutes, osteoarticular diseases, central nervous system, cardiovascular. Based on geography market is divided into Japan, India, China, ROA. The companies evaluated in this report are Medtronic, Inc., Zimmer Holdings, Inc., CONMED Corporation.etc. What makes our report unique? 1) A wide and in depth analysis of the market share and market size estimation based on products, applications and services. 2) We provide longest possible market segmentation comprising of technology , applications and geography. 3) High level analysis of the competitive landscape which in turn includes mergers & acquisitions, collaborations, new product launches and new strategies which major players are following to keep pace with the market.TRANSCRIPT
- 1. ASIA PACIFIC REGENERATIVE MEDICINE MARKET Market Shares, Forecasts & Trends 2014 - 2019 mordorintelligence.com
- 2. REPORT DESCRIPTION Asia-Pacific regenerative market is estimated to reach $9 billion by 2020, from $3 billion in 2013 with a CAGR of 15.04%.Small molecules and biologics show immense potential for the market and estimated to grow at a CAGR of 19%. Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines which are palliative. Technological innovations in stem cell therapy and Tissue engineering, growing prevalence of bone and joint diseases, growing need of orthopaedic surgeries and increase people awareness are the major driving forces for the market.The advancements in nanotechnology and increased in innovation in stem cell therapy account for the further growth of market in this field. The major constrain for the market is regulatory bodies rules and ethical issues related to regenerative medicines and cost of the treatment. Technologically, market is divided into Stem cell therapy, Biomaterial, and tissue engineering. By type of applications, Bone graft substitutes, osteoarticular diseases, central nervous system, cardiovascular. Based on geography market is divided into Japan, India, China, ROA. The companies evaluated in this report are Medtronic, Inc., Zimmer Holdings, Inc., CONMED Corporation.etc. What makes our report unique? 1. A wide and in depth analysis of the market share and market size estimation based on products, applications and services. 2. We provide longest possible market segmentation comprising of technology , applications and geography. 3. High level analysis of the competitive landscape which in turn includes mergers & acquisitions, collaborations, new product launches and new strategies which major players are following to keep pace with the market.
- 3. SAMPLE FIGURES 2013 2014 2015 2016 2017 2018 2019 2020 Global Market Size in USD billion 2013 2014 2015 2016 2017 2018 2019 Asia Pacific Market Size in USD billion
- 4. TABLE OF CONTENTS 1. INTRODUCTION 2. EXECUTIVE SUMMARY 3. MARKET OVERVIEW 3.1 Global Regenerative medicine market 3.2 Current and Future Trends 3.3 Products in the market 3.4 Market Size and Share estimation 3.5 Regenerative medicine Stakeholders 4. MARKET DYNAMICS 4.1 Market Drivers 4.1.1 Technological Innovations in Stem Cell Therapy and Tissue Engineering 4.1.2 Growing prevalence of bone and Joint Diseases 4.1.3 Growing need of Orthopaedic Surgeries Fuels the need of Global regenerative Medicine Market 4.1.4 Increasing people Awareness 4.2 Market Constraints 4.2.1 Regulatory Constraints 4.2.2 Ethical Issues 4.2.3 Cost of Treatment 4.3 Regenerative Medicine Goals and Strategies 4.3.1 Current Markets 4.3.2 Geographic Expansion
- 5. 4.3.3 New Product Innovation 4.4 Porters Five Force Analysis 4.4.1 Bargaining power of suppliers 4.4.2 Bargaining power of buyers 4.4.3 Threat of new entrants 4.4.4 Threat of substitutes 4.4.5 Competitive rivalry 5 MARKET SEGMENTATION 5.1 Introduction 5.2 Market Segmentation, By Type of Technology 5.2.1 Stem Cell Therapy 5.2.2 Biomaterial 5.2.3 Tissue Engineering 5.3 Market Segmentation, By Type of Applications 5.3.1 Bone Graft Substitutes 5.3.2 Osteoarticular Diseases 5.3.3 Dermatology 5.3.4 Cardiovascular 5.3.5 Central nervous system 5.4 Market Segmentation, By Type of Geography 5.4.1 India 5.4.2 Japan
- 6. 5.4.3 China 5.4.4 ROA 6. Competitive Landscape 6.1 New Product Launch 6.2 Market Share Analysis by Key Players 6.3 Mergers & Acquisitions 7. Potential Companies 7.1 Mesoblast Ltd. 7.2 Athersys Inc. 7.3 Neo Stem Inc. 7.4 StemCells Inc. 7.5 Neuralstem Inc.
- 7. ABOUT US Mordor Intelligence is a global market research and consulting firm. Our singular focus is to provide research insights for business success. Our research team has expertise in diverse fields like Agriculture, Healthcare, ICT, Chemicals, Manufacturing, Logistics, Electronics and Automotive. However diverse the expertise maybe, everyone in our team shares one common trait - we love data and we love providing solutions to clients using that data even more. Seeing your business flourish based on our solutions and strategy is what we love the most. DISCLAIMER Mordor Intelligence Reports and their contents, including all the analysis and research containing valuable market information, are provided to a select group of customers in response to orders. Our customers acknowledge when ordering that Mordor Intelligence strategic analysis services are for our customers internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. Mordor Intelligence takes no responsibility for any incorrect information supplied to us by manufacturers or users. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited. For information regarding permissions and sales, please contact: [email protected]
- 8. 7 | Mordor Intelligence ! ! Mordor Intelligence LLP No. 30, Padma Nilaya, Chola Nagar Bangalore, Karnataka, India 560032 +1 781 881 1110 | [email protected] Copyright 2014 Mordor Intelligence LLP All Rights Reserved. This document contains highly confidential information and is the sole property of Mordor Intelligence LLP. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of Mordor Intelligence LLP.